AB Science S.A. | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,933.00
2,099.00
2,284.00
1,508.00
1,739.00
1,701
Cost of Goods Sold (COGS) incl. D&A
331.00
613.00
535.00
758.00
557.00
917
Gross Income
1,602.00
1,486.00
1,749.00
750.00
1,182.00
784
SG&A Expense
24,803.00
24,937.00
33,199.00
37,846.00
36,143.00
35,406
EBIT
23,201.00
23,451.00
31,450.00
37,096.00
34,961.00
34,622
Non Operating Income/Expense
4,574.00
4,165.00
284.00
2,972.00
1,322.00
2,900
Interest Expense
1,003.00
1,275.00
1,250.00
517.00
34.00
23
Pretax Income
19,374.00
20,306.00
32,290.00
34,597.00
33,673.00
31,736
Income Tax
4,763.00
4,194.00
5,574.00
6,901.00
6,551.00
5,675
Consolidated Net Income
14,611.00
16,112.00
26,716.00
27,696.00
27,122.00
26,061
Net Income
14,611.00
16,112.00
26,716.00
27,696.00
27,122.00
26,061
Net Income After Extraordinaries
14,611.00
16,112.00
26,716.00
27,696.00
27,122.00
26,061
Net Income Available to Common
14,611.00
16,112.00
26,716.00
27,696.00
27,122.00
26,061
EPS (Basic)
0.45
0.49
0.78
0.78
0.75
0.69
Basic Shares Outstanding
32,833.30
32,942.20
34,199.50
35,650.00
35,986.50
37,778.60
EPS (Diluted)
0.45
0.49
0.78
0.78
0.75
0.69
Diluted Shares Outstanding
32,833.30
32,942.20
34,199.50
35,650.00
35,986.50
37,778.60
EBITDA
22,876.00
23,013.00
31,058.00
36,485.00
34,525.00
33,953
Non-Operating Interest Income
256.00
255.00
126.00
44.00
-
9

About AB Science

View Profile
Address
3, Avenue George V
Paris Ile-de-France 75008
France
Employees -
Website http://www.ab-science.com
Updated 07/08/2019
AB Science SA engages in the research, development, and sales of protein kinase inhibitor drugs. It develops pharmaceutical products for the treatment of cancer, neurological, and inflammatory diseases. The firm also engages in the field of veterinary medicine.